TX14A-Sap immunotoxin
This immunotoxin was achieved by conjugating/fusing the TX14A to saporin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to cells expressed saposin C and enters cells by receptor-mediated endocytosis. Upon release of the conjugate from endosomes, the saporin toxin catalytically renders the large subunit ribosomes unable to bind the elongation factors and inhibits protein synthesis. It was designed for treatment of prostate, lung, breast, and colon cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AGTO-L072S |
| Pricing | Inquiry |
| Applications | This product is suitable for use in cytotoxicity assay, functional assay and immunotherapy. |
| Host | Human |
| Target | PSAP |
| Species Reactivity | Human |